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Objectives. We sought to assess the outcome of patients with
acute myocardial infarction (MI) and bundle branch block in the
thrombolytic era.
Background. Studies of patients with acute MI and bundle
branch block have reported high mortality rates and poor overall
prognosis.
Methods. The North American population with acute MI and
bundle branch block enrolled in the Global Utilization of Strep-
tokinase and t-PA [tissue-type plasminogen activator] for Oc-
cluded Coronary Arteries (GUSTO-I) trial was matched by age
and Killip class with an equal number of GUSTO-I patients
without conduction defects.
Results. Of all 26,003 North American patients in GUSTO-I,
420 (1.6%) had left (n 5 131) or right (n 5 289) bundle branch
block. These patients had higher 30-day mortality rates than
matched control subjects (18% vs. 11%, p 5 0.003, odds ratio
[OR] 1.8) and were more likely to experience cardiogenic shock
(19% vs. 11%, p 5 0.008, OR 1.78) or atrioventricular block/
asystole (30% vs. 19%, p < 0.012, OR 1.57) and to require
ventricular pacing (18% vs. 11%, p 5 0.006, OR 1.73). Bundle
branch block also carried an independent 53% higher risk for
30-day mortality. Thirty-day mortality rates for patients with
complete, partial and no reversion of the bundle branch block
were 8%, 12% and 20%, respectively (two-tailed chi-square test for
trend 5.61, p 5 0.02, OR 0.34 for complete reversion, OR 0.55 for
partial reversion).
Conclusions. Bundle branch block at hospital admission in
patients with acute MI predicts in-hospital complications and
poor short-term survival.
(J Am Coll Cardiol 1998;31:105–10)
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Before the widespread use of thrombolysis, up to 30% of
patients with acute myocardial infarction (MI) presented to
the hospital with bundle branch block or developed it after
admission (1–6). These patients had an unfavorable short- and
long-term prognosis (6–11). The average in-hospital mortality
rate was 30%, with death mainly related to older age and heart
failure (3,6,9). In addition, high degree atrioventricular (AV)
block complicated the hospital course of 15% of patients with
isolated right bundle branch block (12) and of 30% to 46% of
those with bifascicular block (9,11).
With the advent of reperfusion therapies, resolution of
bundle branch block and AV block have been reported after
both primary coronary angioplasty (13,14) and thrombolysis
(15). A recent subset analysis of the Global Utilization of
Streptokinase and t-PA [tissue-type plasminogen activator] for
Occluded Coronary Arteries (GUSTO-I) and Thrombolysis
and Angioplasty in Myocardial Infarction (TAMI-9) data bases
showed a relatively poorer outcome for patients with acute
chest pain who subsequently developed bundle branch block
than for those who maintained normal intraventricular con-
duction throughout the hospital period (16). However, the
prognosis of patients presenting to the hospital with acute MI
and bundle branch block has not been systematically scruti-
nized in the thrombolytic era.
Methods
Patients. The study group consisted of all North American
patients enrolled in the GUSTO-I trial (17) who had suspected
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acute MI and complete bundle branch block on the preran-
domization electrocardiogram (ECG). The control group was
assembled with an equal number of GUSTO-I patients with a
normal QRS duration on the admission ECG, matched in a
one-to-one fashion with the study group by age and initial
Killip class (two of the strongest predictors of mortality in
GUSTO-I) (18).
Bundle branch block and MI. Patients were included in
this study if they had bundle branch block on the admission
ECG. Both the admission and predischarge ECGs were ana-
lyzed. Right bundle branch and left fascicular blocks were
defined according to the classic criteria (19); the diagnosis of
left anterior fascicular block in patients with Q wave inferior
infarction was made as recommended by Castellanos et al.
(20). We used the following definition of left bundle branch
block: 1) QRS duration $0.125 s in the presence of sinus or
supraventricular rhythm; 2) QS or rS complex in lead V1; and
3) R peak time $0.06 s without Q waves in lead I, V5 or V6
(21). Patients with intermittent or alternating bundle branch
block on the admission ECG were excluded from the study.
Information on “new” versus “old” bundle branch block was
not available in GUSTO-I.
Infarct location was determined by the attending physicians
at time of patient discharge on the basis of all ECG, ventricu-
lographic and clinical data available. Information on in-
hospital complications was used as provided in the case report
form.
Statistical analysis. Baseline characteristics were screened
by univariate regression analysis to identify those associated
with 30-day mortality. The variables “systolic blood pressure”
and “abnormal heart rate” were modeled as suggested by Lee
et al. (18), that is, by providing prognostic estimates for each
unit of systolic blood pressure ,120 mm Hg and by considering
a U-shaped relation for heart rate in which a higher mortality
is expected at very low and high heart rates. Occasional missing
data were replaced by values estimated using a simultaneous
imputation technique (18). The association of bundle branch
block with in-hospital complications was tested. Criteria that
had a univariate statistical significance at p , 0.1 were included
into a stepwise logistic regression model to identify indepen-
dent (p , 0.05) predictors of both 30-day mortality and
reversion of bundle branch block. The predictive performance
of the logistic model for 30-day mortality was examined using
the Hosmer-Lemeshow test. Variable modeling was performed
with EGRET software (22), and logistic regression models
with EGRET and SAS (23).
Results
Bundle branch block was present on 420 baseline ECGs of
the 26,003 North American GUSTO-I patients (1.6%). One
hundred and thirty-one patients presented with left bundle
branch block and 289 patients presented with right bundle
branch block (isolated in 133 patients and associated with left
anterior fascicular block in 145 patients and with left posterior
fascicular block in 11 patients). Baseline characteristics are
listed in Table 1. Male gender and diabetes were more
prevalent among patients with bundle branch block.
Most patients with bundle branch block at hospital admis-
sion had anterior wall infarction. The association was particu-
larly strong for patients with right bundle branch block (188
[65%] of 289). Patients with left bundle branch block presented
more frequently with other infarct locations (anterior infarct in
46 [35%] of 131 patients). Peak total creatine kinase was
higher among patients with bundle branch block.
Thirty-day mortality. Patients admitted with bundle branch
block had a higher 30-day mortality than their matched control
subjects (76 [18%] vs. 46 [11%], p 5 0.003, odds ratio [OR]
1.8). The conduction defects associated with most deaths were
right bundle branch block plus left anterior fascicular block
Abbreviations and Acronyms
AV 5 atrioventricular
ECG 5 electrocardiogram, electrocardiographic
GUSTO-I 5 Global Utilization of Streptokinase and t-PA
[tissue-type plasminogen activator] for Occluded
Coronary Arteries
MI 5 myocardial infarction
OR 5 odds ratio
TAMI-9 5 Thrombolysis and Angioplasty in Myocardial
Infarction
t-PA 5 tissue-type plasminogen activator
Table 1. Baseline Characteristics
Variable
Patients With BBB
(n 5 420)
Patients Without BBB
(n 5 420) p Value
Age (yr) 69.54 (61.9, 76.2) 69.53 (61.9, 76) 0.93
Men 317 (75%) 259 (61%) , 0.001
Weight (kg) 78.8 (68.2, 88.2) 76 (67.6, 85.4) 0.26
Height (cm) 172 (162.5, 180) 170 (160, 177.3) 0.88
SBP (mm Hg) 127 (110, 143) 126 (110, 142) 0.31
DBP (mm Hg) 75 (64, 86) 75.5 (64, 88) 0.39
HR (beats/min) 78 (64, 90) 72 (62, 88) 0.07
Killip class 1.32 6 0.65 1.32 6 0.65 1
Peak CK (IU) 1,964 (717, 3,901) 1,557 (642, 2,736) , 0.001
Hypertension 180 (43%) 195 (46%) 0.29
Diabetes 99 (23%) 70 (17%) 0.01
Current smoker 120 (28%) 136 (32%) 0.23
Ex-smoker 260 (62%) 253 (60%) 0.62
Family Hx of CAD 160 (38%) 165 (39%) 0.72
Previous MI 99 (23%) 81 (19%) 0.13
Previous CABG 26 (6%) 22 (5%) 0.55
Ant wall MI 234 (56%) 187 (44%) , 0.001
Time to Tx (min) 165 (120, 235) 184 (125, 244) 0.29
Tx with accelerated t-PA 109 (26%) 117 (28%) 0.53
Data presented are median (lower, upper quartiles), mean value 6 SD or
number (%) of patients. Ant 5 anterior; BBB 5 bundle branch block; CAD 5
coronary artery disease; CABG 5 coronary artery bypass graft surgery; CK 5
creatine kinase; DBP 5 diastolic blood pressure; HR 5 heart rate; Hx 5 history;
MI 5 myocardial infarction; SBP 5 systolic blood pressure; t-PA 5 tissue-type
plasminogen activator; Tx 5 treatment.
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(23%, p , 0.001, OR 2.5) and isolated right bundle branch
block (21%, p 5 0.003, OR 2.17) (Table 2). Among nonsurvi-
vors, time from hospital admission to death (median 2 days)
was similar for patients with and without bundle branch block
(interquartile bounds 1 to 7.5 and 1 to 7, vs. 2 days, respec-
tively).
Other univariate predictors of 30-day mortality were diabe-
tes (p , 0.001, OR 2.44), anterior infarction (p , 0.001, OR
2.39), abnormal heart rate at hospital admission (heart rate
deviating in any direction from a central value of 60 beats/min)
(p , 0.001, OR 1.02), hypotension (systolic blood pressure
,120 mm Hg) (p , 0.001, OR 0.97), Killip class (p , 0.001,
OR 2.5 for class 2, OR 5.2 for class 3, OR 4.48 for class 4), age
(p , 0.001, OR 1.04/year) and smoking status (current,
ex-smoker or never smoked) (p 5 0.004, OR 0.75 for current
smoker, OR 0.48 for ex-smoker). Hypertension, weight, history
of cerebrovascular disease, previous infarction or coronary
artery bypass graft surgery, time to treatment and treatment
with accelerated t-PA did not predict mortality.
After adjusting for all relevant baseline prognostic variables
(18), bundle branch block carried a 53% higher risk for 30-day
mortality (p 5 0.050, OR 1.53, 95% confidence interval 1.0 to
2.33). Independent predictors for 30-day mortality are listed in
Table 3. The “goodness of fit” of this model was evaluated with
the Hosmer-Lemeshow test, which indicated that the model fit
well.
In-hospital complications and death. Patients with bundle
branch block were more likely than their paired control
subjects to experience asystole or AV block, or both (30% vs.
19%, p 5 0.012, OR 1.57). The use of ventricular pacing
(which in GUSTO-I was based on the attending physician’s
judgment) was more frequent in the group with bundle branch
block (18% vs. 11%, p 5 0.006, OR 1.73). In addition, patients
with conduction defects were more likely to develop sustained
ventricular tachycardia or fibrillation (11% vs. 7%, p 5 0.031,
OR 1.73) and cardiogenic shock (19% vs. 11%, p 5 0.008, OR
1.78). Acute mitral regurgitation, ventricular septal defect and
tamponade affected ,3% of patients in either group.
Seventy-four patients with bundle branch block (18%) died
during the hospital period, including five who died after 30
days from the index event and excluding seven who died after
hospital discharge but within 30 days of the infarct. Sixty-five
in-hospital deaths had a cardiac cause and four a noncardiac
cause, and in five the cause was not recorded. Of the 420
control subjects, 45 (11%) died in the hospital, including two
who died after 30 days and excluding three who died after
hospital discharge but within 30 days of the infarct. Of these 45
control subjects, 40 died of a cardiac cause and four of a
noncardiac cause, and in one the cause was not recorded.
Only eight autopsy reports were available from the enroll-
ing sites for patients who died in the hospital (six for patients
with bundle branch block, two for control subjects). Among
patients with bundle branch block, two deaths were caused by
cardiac rupture, one by heart failure, one by “asystole,” one by
a ruptured aortic aneurysm and one presumably by bilateral
aspiration bronchopneumonia.
Post-thrombolysis reversion of the bundle branch block:
beneficial effect on mortality. Complete reversion of the bun-
dle branch block was seen in 51 patients (12%), whereas partial
reversion occurred in 49 patients (12%) (Table 4). This
reversion was not associated with changes in heart rate (86.7 6
23.5 beats/min at admission vs. 80.46 6 15.3 beats/min on
predischarge ECG; p 5 0.12). Predischarge ECGs were not
available for 13 patients admitted to the hospital with bundle
branch block, 11 of whom died soon after admission. The
Table 2. Thirty-Day Mortality by Type of Bundle Branch Block
Type of BBB at
Admission
Observed 30-Day Mortality
No. (%) of Pts p Value OR (95% CI)
RBBB, isolated
(n 5 133)
28 (21%) 0.003 2.17 (1.25–3.75)
RBBB 1 LAFB
(n 5 145)
34 (23%) , 0.001 2.49 (1.72–3.48)
RBBB 1 LPFB
(n 5 11)
1 (10%) 0.084 0.81 (0.02–4.51)
LBBB
(n 5 131)
13 (10%) 0.74 0.9 (0.44–1.78)
BBB 5 bundle branch block; CI 5 confidence interval; LAFB 5 left anterior
fascicular block; LBBB 5 left bundle branch block; LPFB 5 left posterior
fascicular block; OR 5 odds ratio; Pts 5 patients; RBBB 5 right bundle branch
block.
Table 3. Independent Predictors of 30-Day Mortality
p Value Adjusted OR (95% CI)
Observed
30-Day
Mortality (%)
Age , 0.001 1.05/year (1.03–1.07) —
SBP* , 0.001 0.98/mm Hg (0.96–0.99) —
Ant MI , 0.001 2.19 (1.42–3.4) 20
Killip class 0.002 1.58 (1.18–2.09)
I 11
II 23
III 38
Abnormal HR† 0.006 1.02/beat (1.0–1.03) —
Diabetes 0.008 1.85 (1.17–2.92) 25
BBB 0.050 1.53 (1.00–2.33) 18
*Odds ratio (OR) provided for each decrease of 1 mm Hg for a systolic blood
pressure (SBP) of 120 mm Hg. †Odds ratio provided for each single beat/min of
difference (in any direction) for a heart rate (HR) of 60 beats/min. Other
abbreviations as in Tables 1 and 2.
Table 4. Reversion Rates by Initial Bundle Branch Block Type
Initial Conduction Defect
Complete Reversion
Rate
Partial Reversion Rate,
Predischarge
Conduction Defect
RBBB (n 5 133) 14 (10%) —
RBBB1LAFB (n 5 145) 22 (15%) 38 (26%, RBBB
4 (3%), LAFB
RBBB1LPFB (n 5 11) 1 (9%) 5 (45%), RBBB
LBBB (n 5 131) 14 (11%) 2 (2%), LAFB
Data presented are number (%) of patients. Abbreviations as in Table 2.
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remaining 307 ECGs showed persistence or worsening of the
bundle branch block (n 5 275), nonspecific conduction defects
(n 5 21), ventricular pacing (n 5 9) or agonal rhythm (n 5 2).
Thirty-day mortality rates for patients with complete and
partial reversion of the bundle branch block were 8% and 12%,
respectively, whereas patients with persistent bundle branch
block had a mortality rate of 18% (two-tailed chi-square test
for trend 3.75, p 5 0.053, OR 0.39 for complete reversion, OR
0.64 for partial reversion). When patients with missing predis-
charge ECGs (a nonrandom occurrence) were analyzed in the
group of “nonreverters,” the 30-day mortality rate for this
group was 20% (two-tailed chi-square test for trend 5.61, p 5
0.02, OR 0.34 for complete reversion, OR 0.55 for partial
reversion).
Angiographic evaluation. Two-hundred and fifty-six pa-
tients with bundle branch block underwent angiographic eval-
uation after receiving thrombolytic therapy, as part of an
angiographic substudy (n 5 16) (24) or by recommendation of
the attending physician (n 5 240). The culprit lesion in patients
with right bundle branch block (isolated or with left fascicular
block) was observed more often in the left anterior descending
coronary artery, whereas the culprit lesion in patients with left
bundle branch block was located more often in the right
coronary artery (Table 5). Patients with left bundle branch
block were slightly more likely to have circumflex occlusion
than patients with right bundle branch block (p 5 0.051).
Information on coronary lesions was not available for 12
patients, three of whom died before undergoing catheteriza-
tion. Percutaneous transluminal coronary angioplasty was per-
formed in 92 patients with bundle branch block, 19 of whom
showed partial or total reversion of their conduction defect
after the procedure.
Discussion
The main finding of our study is that both 30-day and 1-year
survival rates in patients with acute MI and bundle branch
block treated with thrombolysis are poorer than those for
similar patients with no conduction defects. Previous reports
have suggested that this unfavorable prognosis is determined
by older age (25,26) or heart failure (9,12,27), or both (6). We
found that even when patients were matched with control
subjects for age and Killip class, bundle branch block remained
an independent predictor of mortality. Although the associa-
tion had only borderline statistical significance, these patients
were 53% more likely to die within 30 days of hospital
admission than their matched control subjects. Asystole or AV
block, ventricular arrhythmias and cardiogenic shock were also
more frequent among patients with bundle branch block.
A recent analysis of the GUSTO-I and TAMI-9 data bases
showed a 30-day mortality rate of only 8.7% for patients with
bundle branch block (16). This may reflect differences in the
groups studied. The previous analysis included only patients
who participated in an ischemia monitoring substudy who did
not have bundle branch block at hospital admission. Most of
those patients (77.6%) had transient blocks, perhaps reflecting
ongoing reperfusion, whereas an equivalent proportion of
patients in our study (76.2%) had persistent blocks. The
subgroup with persistent blocks in the previous study had a
mortality rate similar to that found in our study (19.4% vs.
18%). Finally, the association of conduction defects with heart
rate was not explored in the previous study, and patients with
rate-dependent bundle branch blocks—and higher survival
rates—may have been included in the analysis.
The relation between bundle branch block and mortality is
complex. Autopsy studies on patients dying shortly after in-
farction have shown little or no necrosis, edema or inflamma-
tion of the conduction system (28,29). This absence of evident
injury to the bundle branches, and the fact that the Purkinje
fibers are more resistant to ischemia compared with myocytes,
points rather to a dynamic phenomenon responsible for the
mortality. Experimental observations in the isolated ventricle
may provide a biologic rationale for this hypothesis by under-
scoring the role of the “near-necrotic zone.” When a band of
necrotic myocardium is placed on the surface of a normal
ventricle from a second animal, myocytes and conducting fibers
show functional depression, and excitation and conduction are
soon abolished (30). If the near-necrotic zone involves the
conduction system, complete AV block or bundle branch block
can occur. These functional changes in the conduction system
remain after removing the necrotic tissue, and the degree of
recovery is a function of the duration of the experiment (30). In
addition, the bundle branches receive both sympathetic and
vagal innervation (31), which may be interrupted during myo-
cardial ischemia (32). A reentry circuitry provided by the
blocked bundle branch, local ionic changes induced by isch-
emia and functional autonomic denervation all may contribute
to ventricular arrhythmias. Death from both “primary” and
“late” ventricular fibrillation is well documented in patients
with bundle branch block (10,33–36); we found that their risk
for ventricular arrhythmias was as high as their risk for
cardiogenic shock.
Conduction defects often resolve during the hospital pe-
riod. The overall reversion rate for bundle branch block of
24% in our study was associated with a 50% relative reduction
in 30-day mortality (from 20% to an average of 10%). Thus,
patients who recovered normal intraventricular conduction
Table 5. Infarct-Related Artery by Type of Bundle Branch Block
IRA
RBBB
(n 5 170)
LBBB
(n 5 86)
LMCA 4 (2%) 0
LAD 98 (58%) 26 (30%)*
LCx 14 (8%) 14 (16%)
RCA 43 (25%) 38 (44%)†
Graft 2 (1%) 4 (5%)
Uncertain 8 (5%) 4 (5%)
None 1 (0.5%) 0
*p , 0.001. †p 5 0.002. Data presented are number (%) of patients. IRA 5
infarct-related artery; LAD 5 left anterior descending coronary artery; LCx 5
left circumflex artery; LMCA 5 left main coronary artery; RCA 5 right coronary
artery; other abbreviations as in Table 2.
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had a prognosis similar to that of patients who never developed
bundle branch block. This finding also has been reported
among subjects not receiving thrombolysis (10,12,27). The
graded effect on survival in our study (greater for patients
undergoing complete reversion than for those undergoing
partial reversion) suggests a myocardial mechanism of death
linked to the bundle branch block. Whether the reversion of
the conduction defect results from spontaneous or from ther-
apeutically induced reperfusion, it is possible that the final
common pathway in reducing mortality involves the salvage of
myocardium or changes in the electrophysiologic milieu that
tend to prevent ventricular arrhythmias, or both.
Bundle branch block location. Most patients with conduc-
tion defects in our study had right bundle branch block, alone
or in combination with a left fascicular block. This could be
because the right bundle branch is a narrow structure, rela-
tively vulnerable to focal ischemia. The blood supply to the
proximal segment of the right bundle is derived from the AV
node artery, whereas that for the remaining two-thirds of the
right bundle and for the left anterior fascicle is provided by the
septal branches of the left anterior descending coronary artery
(37,38). This and the fact that anterior infarcts portend an
intrinsically worse prognosis (39) could explain both the asso-
ciation of right bundle branch block with anterior infarcts and
the higher mortality (40,41). Autopsy analysis in these patients
has revealed that the infarct area always includes the ventric-
ular septum (33,38).
The less frequent compromise of the left bundle during
acute MI has been observed by other investigators (2,16), and
it may reflect the diffuse structure of the left bundle. The main
left bundle branch and its posterior division receive a dual
blood supply from both a septal branch of the left anterior
descending coronary artery and the AV node artery (38). Thus,
only extensive damage that includes most of the ventricular
septum and the anterior wall may interrupt the conduction at
the left bundle (42). The greater survival of patients who
develop left bundle branch block has not been a consistent
finding across studies (2,6,10,33). It might reflect either a
predominantly patch-like necrotic process, the fact that most
infarcts were nonanterior, or a prehospital survival bias of
patients with newly acquired left bundle branch block, which
would drive the selective admission of patients with “old,”
more benign left bundle branch blocks.
Study limitations. The relatively low incidence of bundle
branch block (1.6%) among GUSTO-I patients may originate
from differences in design from previous studies, which in-
cluded either patients with late-onset bundle branch block (i.e.,
developed during the hospital period) (1,16,26), patients with
alternating left and right bundle branch blocks (16) or patients
with isolated fascicular blocks (1). It may also reflect a
selection bias in GUSTO-I, with preferential enrollment of
patients in whom the diagnosis of acute MI was obvious
despite the presence of the conduction defect; this might
explain the prevalent association of left bundle branch block
with nonanterior infarcts. Thus, the results of this study may
apply best to those patients with acute MI and bundle branch
block who are enrolled in clinical trials.
Notwithstanding the relatively small sample size, bundle
branch block emerged as an important prognostic factor, and
thus our findings may apply better to patients with bundle
branch block who have a higher ECG risk.
Patients with bundle branch block probably had larger
infarcts than their control subjects. A highly reliable indicator
of infarct size was not available in our study. Peak creatine
kinase, MB fraction varies with reperfusion status, and its
blood level values were not reported in many patients. Peak
total creatine kinase, which was higher among patients with
bundle branch block, is a nonspecific marker for infarct size
(43,44). Killip class may not provide accurate information on
heart failure accompanying large infarcts; aside from left
ventricular function, other variables may be captured by Killip
class. However, Killip class remained a powerful prognostic
factor for mortality in the entire GUSTO-I population (18).
This suggests that patients with and without bundle branch
block would be similarly affected in analyses that include Killip
class.
Clinical implications and conclusions. The advent of
reperfusion therapies has not diminished the strong associa-
tion between bundle branch block and early mortality in
patients with acute MI. Their poor prognosis does not seem to
be related exclusively to the development of AV block, a larger
infarct size or more severe heart failure. The mechanism
ultimately leading to death is complex and appears to involve
the conduction defect, because in our study survival was poorer
after partial reversion of the bundle branch block than after
complete reversion. In addition, the contribution of septal
asynergy, late bradyarrhythmias and electrical instability may
be more important than previously appreciated.
Recommendations for patients who present with bundle
branch block during acute MI have focused on the relief of
heart failure and on the appropriateness of prophylactic
pacing (2,11,33,45). The use of ventricular pacing has not
gained widespread acceptance because it does not seem to
improve in-hospital survival and it may be associated with
serious complications (2,45); prophylactic placement of
external pacing pads seems a more attractive alternative
(46). In contrast, therapeutic procedures that optimally
restore myocardial perfusion might prevent or reverse the
development of near-necrotic lesions in the conduction
system altogether by decreasing its time of exposure to
ischemia (12,15).
The confirmation of a role for ventricular arrhythmias in
the death of patients with bundle branch block could lead to
prevention of early mortality by intensifying cardiac monitor-
ing in the coronary unit and by instituting specific measures in
those patients at higher risk. Effective antiarrhythmic therapies
could include the prophylactic placement of external patches
for use with portable automatic external defibrillators and the
use of implantable cardioverter-defibrillators.
109JACC Vol. 31, No. 1 SGARBOSSA ET AL.
January 1998:105–10 OUTCOME OF MI WITH BUNDLE BRANCH BLOCK
We are indebted to Amanda Stebbins, MS for professional assistance with data
base querying and to Patricia Williams for expert editorial advice.
References
1. Col JJ, Weinberg SL. The incidence and mortality of intraventricular
conduction defects in acute myocardial infarction. Am J Cardiol 1972;29:
344–50.
2. Godman MJ, Lassers BW, Julian DG. Complete bundle branch block
complicating acute myocardial infarction. N Engl J Med 1970;282:237–40.
3. Sugiura T, Iwasaka T, Hasegawa T, et al. Factors associated with persistent
and transient fascicular blocks in anterior wall acute myocardial infarction.
Am J Cardiol 1989;63:784–7.
4. Hollander G, Nadiminti V, Lichstein E, Greengart A, Sanders M. Bundle
branch block in acute myocardial infarction. Am Heart J 1983;105:738–43.
5. McAnulty JH, Rahimtoola SH. Bundle branch block. Prog Cardiovasc Dis
1983;26:333–54.
6. Dubois C, Pie´rard LA, Smeets JP, Foidart G, Legrand V, Kulbertus HE.
Short- and long-term prognostic importance of complete bundle branch
block complicating acute myocardial infarction. Clin Cardiol 1988;11:292–6.
7. Waugh RA, Wagner GS, Haney TL, Rosati RA, Morris JJ Jr. Immediate and
remote prognostic significance of fascicular block during acute myocardial
infarction. Circulation 1973;42:765–75.
8. Lamas GA, Muller JE, Turi ZG, et al., and the MILIS Study Group. A
simplified method to predict occurrence of complete heart block during
acute myocardial infarction. Am J Cardiol 1986;57:1213–9.
9. Hindman MC, Wagner GS, JaRo M, et al. The clinical significance of bundle
branch block complicating acute myocardial infarction. I. Clinical character-
istics, hospital mortality, and one-year follow-up. Circulation 1978;58:679–
88.
10. Fisch GR, Zipes DP, Fisch C. Bundle branch block and sudden death. Prog
Cardiovasc Dis 1980;23:187–224.
11. Klein RC, Vera Z, Mason DT. Intraventricular conduction defects in acute
myocardial infarction: incidence, prognosis, and therapy. Am Heart J
1984;4:1007–13.
12. Ricou F, Nicod P, Gilpin E, Henning H, Ross J. Influence of right bundle
branch block on short- and long-term survival after acute myocardial
infarction. J Am Coll Cardiol 1991;17:858–63.
13. Wilber D, Walton J, O’Neill W, Laufer N, Pitt B. Effects of reperfusion on
complete heart block complicating anterior myocardial infarction. J Am Coll
Cardiol 1984;6:1315–21.
14. Moreyra AE, Horvitz L, Presant SB, Kostis JB. Resolution of complete heart
block after right coronary artery angioplasty. Am Heart J 1988;115:179–81.
15. Roth A, Miller HI, Glick A, Barbash GI, Laniado S. Rapid resolution of new
right bundle branch block in acute myocardial infarction patients after
thrombolytic therapy. Pacing Clin Electrophysiol 1993;16:13–6.
16. Newby KH, Pisano E, Krucoff MW, Green C, Natale A. Incidence and
clinical relevance of the occurrence of bundle branch block in patients
treated with thrombolytic therapy. Circulation 1996;94:2424–8.
17. The GUSTO Investigators. An international randomized trial comparing
four thrombolytic strategies for acute myocardial infarction. N Engl J Med
1993;329:673–82.
18. Lee KL, Woodlief LH, Topol EJ, et al., for the GUSTO-I Investigators.
Predictors of 30-day mortality in the era of reperfusion for acute myocardial
infarction: results from an international trial of 41,021 patients. Circulation
1995;91:1659–68.
19. Willems JL, Robles de Medina EO, Bernard R, et al. Criteria for intraven-
tricular conduction disturbances and pre-excitation. J Am Coll Cardiol
1985;5:1261–75.
20. Castellanos A, Pina IL, Zaman L, Myerburg RJ. Recent advances in the
diagnosis of fascicular blocks. Cardiol Clin 1987;5:469–88.
21. Sgarbossa EB, Pinski SL, Barbagelata A, et al., for the GUSTO-I Investiga-
tors. Electrocardiographic diagnosis of evolving acute myocardial infarction
in the presence of left bundle branch block. N Engl J Med 1996;334:481–7.
22. EGRET Reference Manual. Seattle (WA): Statistics and Epidemiological
Research Corporation, 1990.
23. SAS Version 6.11 for UNIX. Cary (NC): SAS Institute Inc., 1996.
24. The GUSTO Angiographic Investigators. The effects of tissue plasminogen
activator, streptokinase, or both on coronary-artery patency, ventricular
function, and survival after acute myocardial infarction. N Engl J Med
1993;329:1615–22.
25. Bauer GE, Julian DG, Valentine A. Bundle-branch block in acute myocar-
dial infarction. Br Heart J 1965;27:724–30.
26. Domenighetti G, Perret C. Intraventricular conduction disturbances in acute
myocardial infarction: short- and long-term prognosis. Eur J Cardiol 1980;
11:51–9.
27. Lie KI, Wellens HJ, Schuilenburg RM, Becker AE, Durrer D. Factors
influencing prognosis of bundle branch block complicating acute antero-
septal infarction. Circulation 1974;50:935–41.
28. Hackel DB, Wagner G, Ratliff NB, Cies A, Estes EH. Anatomic studies of
the cardiac conducting system in acute myocardial infarction. Am Heart J
1972;83:77–81.
29. Becker AE, Lie KI, Anderson RH. Bundle-branch block in the setting of
acute antero-septal myocardial infarction: clinicopathological correlation. Br
Heart J 1978;40:773–82.
30. Udelnov MG. The role of necrosis in the origin of electrocardiographic
alterations characteristic of myocardial infarction. Circulation 1961;24:110–
22.
31. Crick SJ, Wharton J, Sheppard MN, et al. Innervation of the human cardiac
conduction system: a quantitative immunohistochemical and histochemical
study. Circulation 1994;89:1697–1708.
32. Barber MJ, Mueller TM, Davies BG, Gill RM, Zipes DP. Interruption of
sympathetic and vagal-mediated afferent responses by transmural myocardial
infarction. Circulation 1985;72:623–31.
33. Norris RM, Mercer CJ, Croxon MS. Conduction disturbances due to
anteroseptal myocardial infarction and their treatment by endocardial
pacing. Am Heart J 1972;84:560–6.
34. Brezins M, Elyassov S, Elimelech I, Roguin N. Comparison of patients with
acute myocardial infarction with and without ventricular fibrillation. Am J
Cardiol 1996;78:948–50.
35. Lie KI, Liem KL, Schuilenburg RM, David GK, Durrer D. Early identifica-
tion of patients developing late in-hospital ventricular fibrillation after
discharge from the coronary unit: a 51⁄2 year retrospective and prospective
study of 1,897 patients. Am J Cardiol 1978;41:674–7.
36. Norris RM, Sammel NL. Predictors of late hospital death in acute myocar-
dial infarction. Prog Cardiovasc Dis 1980;23:129–40.
37. Gann D, Balachandran PK, El-Sherif N, Samet P. Prognostic significance of
chronic versus acute bundle branch block in acute myocardial infarction.
Chest 1975;67:298–303.
38. James TN, Burch GE. Blood supply of the human intraventricular septum.
Circulation 1958;17:391–6.
39. Stone PH, Raabe DS, Jaffe AS, et al. Prognostic significance of location and
type of myocardial infarction: independent adverse outcome associated with
anterior location. J Am Coll Cardiol 1988;11:453–63.
40. Hindman MC, Wagner GS, JaRo M, et al. The clinical significance of bundle
branch block complicating acute myocardial infarction. II. Indications for
temporary and permanent pacemaker insertion. Circulation 1978;58:689–99.
41. Julian DG, Valentine PA, Miller GG. Disturbances of rate, rhythm and
conduction in acute myocardial infarction. Am J Med 1964;37:915–27.
42. Scheinman M, Brenman B. Clinical and anatomic implications of intraven-
tricular conduction block in acute myocardial infarction. Circulation 1972;
46:753–60.
43. Georges JL, Spentchian M, Caubel C, et al. Time course of troponin I,
myoglobin, and cardiac enzyme release after electrical cardioversion. Am J
Cardiol 1996;78:825–7.
44. Adams JE III, Bodor JS, Davila-Roman VG, et al. Cardiac troponin I: a
marker with high specificity for cardiac injury. Circulation 1993;88:101–6.
45. Roth A, Borsuk Y, Keren G, et al. Right bundle branch block of unknown
age in the setting of acute myocardial infarction: an attempt to define who
should be paced prophylactically. Pacing Clin Electrophysiol 1995;18:1496–
1508.
46. Ryan TJ, Anderson JL, Antman EM, et al. ACC/AHA guidelines for the
management of patients with acute myocardial infarction: executive sum-
mary. Circulation 1996;94:2341–50.
110 SGARBOSSA ET AL. JACC Vol. 31, No. 1
OUTCOME OF MI WITH BUNDLE BRANCH BLOCK January 1998:105–10
